K.M. Anderson

2.5k total citations · 2 hit papers
60 papers, 1.9k citations indexed

About

K.M. Anderson is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, K.M. Anderson has authored 60 papers receiving a total of 1.9k indexed citations (citations by other indexed papers that have themselves been cited), including 34 papers in Molecular Biology, 11 papers in Oncology and 11 papers in Cancer Research. Recurrent topics in K.M. Anderson's work include Prostate Cancer Treatment and Research (6 papers), Mitochondrial Function and Pathology (5 papers) and Cancer Cells and Metastasis (5 papers). K.M. Anderson is often cited by papers focused on Prostate Cancer Treatment and Research (6 papers), Mitochondrial Function and Pathology (5 papers) and Cancer Cells and Metastasis (5 papers). K.M. Anderson collaborates with scholars based in United States, Canada and Belgium. K.M. Anderson's co-authors include Shutsung Liao, Shutsung Liao, Senmaw Fang, James R. Berenson, Allan Lipton, J. Sybil Biermann, Gary C. Yee, Robert A. Kyle, Bruce E. Hillner and Marvin Rubenstein and has published in prestigious journals such as Nature, Journal of Biological Chemistry and Journal of Clinical Oncology.

In The Last Decade

K.M. Anderson

57 papers receiving 1.7k citations

Hit Papers

Selective Retention of Dihydrotestosterone by Prostatic N... 1968 2026 1987 2006 1968 1969 100 200 300 400

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
K.M. Anderson United States 16 671 579 529 361 249 60 1.9k
L. Castagnetta Italy 28 711 1.1× 451 0.8× 443 0.8× 327 0.9× 908 3.6× 89 2.6k
Wilfried Rombauts Belgium 30 1.4k 2.1× 782 1.4× 134 0.3× 733 2.0× 1.1k 4.4× 94 2.7k
A. Brodie United States 28 684 1.0× 407 0.7× 502 0.9× 271 0.8× 1.5k 5.9× 64 2.5k
I Mowszowicz France 30 1.6k 2.4× 1.4k 2.4× 153 0.3× 277 0.8× 822 3.3× 84 2.9k
Thomas J. Brown United States 24 651 1.0× 348 0.6× 242 0.5× 127 0.4× 536 2.2× 66 2.6k
A.L. Latner United Kingdom 21 618 0.9× 236 0.4× 146 0.3× 70 0.2× 84 0.3× 111 1.5k
Dale J. Christensen United States 24 1.5k 2.2× 160 0.3× 399 0.8× 278 0.8× 728 2.9× 48 2.4k
Lewis Aronow United States 22 542 0.8× 246 0.4× 155 0.3× 84 0.2× 332 1.3× 44 1.3k
Jack Pensky United States 27 707 1.1× 282 0.5× 229 0.4× 80 0.2× 123 0.5× 47 3.0k
Balakrishna L. Lokeshwar United States 19 422 0.6× 96 0.2× 162 0.3× 165 0.5× 141 0.6× 32 1.8k

Countries citing papers authored by K.M. Anderson

Since Specialization
Citations

This map shows the geographic impact of K.M. Anderson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by K.M. Anderson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites K.M. Anderson more than expected).

Fields of papers citing papers by K.M. Anderson

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by K.M. Anderson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by K.M. Anderson. The network helps show where K.M. Anderson may publish in the future.

Co-authorship network of co-authors of K.M. Anderson

This figure shows the co-authorship network connecting the top 25 collaborators of K.M. Anderson. A scholar is included among the top collaborators of K.M. Anderson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with K.M. Anderson. K.M. Anderson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Anderson, K.M., Patrick Guinan, & Marvin Rubenstein. (2013). Normoxic or hypoxic CD44/CD41 a 2 B 1 integrin-positive prostate PC3 cell side fractions and cancer stem cells. Medical Oncology. 31(1). 779–779. 4 indexed citations
2.
Anderson, K.M., et al.. (2009). In vitro effects of dichloroacetate and CO2 on hypoxic HeLa cells.. PubMed. 29(11). 4579–88. 32 indexed citations
3.
Anderson, K.M., et al.. (2009). Are cancer stem cells concentrated in more alkaline hypoxic regions of tumors?. Medical Hypotheses. 74(5). 868–870. 3 indexed citations
5.
Anderson, K.M., et al.. (2004). Acute changes in U937 nuclear Ca2+ preceding type 1 "apoptotic" programmed cell death due to MK 886.. PubMed. 24(5A). 2601–15. 5 indexed citations
7.
Anderson, K.M., Waddah A. Alrefai, Pradeep K. Dudeja, et al.. (2002). Increased cytosol Ca2+ and type 1 programmed cell death in Bcl-2-positive U937 but not in Bcl-2-negative PC-3 and Panc-1 cells induced by the 5-lipoxygenase inhibitor MK 886. Prostaglandins Leukotrienes and Essential Fatty Acids. 66(4). 443–452. 10 indexed citations
8.
Anderson, K.M., Waddah A. Alrefai, Colin R. Anderson, Philip Bonomi, & Jules E. Harris. (2002). Mk 886 Functions As A Radiomimetic Agent: Genomic Responses Related to Oxidative Stress, The Cell Cycle, Proliferation and Programmed Cell Death in Panc-1 Cells. Advances in experimental medicine and biology. 507. 451–456. 3 indexed citations
9.
Anderson, K.M. & Jennifer Harris. (2001). Comments on the unreasonable effectiveness of the biological and especially medical sciences. Medical Hypotheses. 56(4). 431–433.
10.
Anderson, K.M. & James Harris. (2001). Is induction of type 2 programmed death in cancer cells from solid tumors directly related to mitochondrial mass?. Medical Hypotheses. 57(1). 87–90. 5 indexed citations
11.
Anderson, K.M., et al.. (2000). Widespread countervailing genomic responses induced by chemotherapy or radiation as a cause of therapeutic failure. Medical Hypotheses. 54(6). 1000–1002. 2 indexed citations
12.
Anderson, K.M., G. Ells, Philip Bonomi, & James Harris. (1999). Free radical spin traps as adjuncts for the prevention and treatment of disease. Medical Hypotheses. 52(1). 53–57. 8 indexed citations
13.
Anderson, K.M., Thomas M. Seed, Di Ou, & Jennifer Harris. (1999). Free radicals and reactive oxygen species in programmed cell death. Medical Hypotheses. 52(5). 451–463. 51 indexed citations
14.
Dudeja, Pradeep K., K.M. Anderson, Jack Harris, Lela Buckingham, & John S. Coon. (1995). Reversal of Multidrug-Resistance Phenotype by Surfactants: Relationship to Membrane Lipid Fluidity. Archives of Biochemistry and Biophysics. 319(1). 309–315. 128 indexed citations
15.
Anderson, K.M., Jennifer Harris, & Philip Bonomi. (1994). Potential applications of apoptosis in modifying the biological behavior of therapeutically refractory cancers. Medical Hypotheses. 43(4). 207–213. 2 indexed citations
16.
Brown, M.D., K.M. Anderson, Hitesh Patel, A. J. Hopfinger, & James Harris. (1992). Eicosatetraynoic and arachidonic acid-induced changes in cell membrane fluidity consonant with differences in computer-aided design-structures. Biochimica et Biophysica Acta (BBA) - Biomembranes. 1105(2). 285–290. 18 indexed citations
17.
Wilson, Donald E., K.M. Anderson, & Thomas M. Seed. (1990). Ultrastructural evidence for differentiation in a human glioblastoma cell line treated with inhibitors of eicosanoid metabolism. Neurosurgery. 27(4). 523–523. 22 indexed citations
19.
Anderson, K.M.. (1971). A probable effect of diabetes mellitus on incorporation of amino acids into proteins catalyzed by isolated rat liver nuclei. Cellular and Molecular Life Sciences. 27(3). 333–335. 1 indexed citations
20.
Anderson, K.M. & John A. Kellen. (1970). Suppression of carcinogen-induced rat mammary tumor formation by Actinomycin D. Cellular and Molecular Life Sciences. 26(9). 1000–1001. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026